CCO Independent Conference Coverage: Clinical Impact of New Data From EASL 2021

CCO slides on the impact of racial disparities in HCV care; key strategies on recognizing and reducing inadequate HCV care in the US and globally

Prof Ashley Brown, BSc, MD, FRCP Ahmed M. Elsharkawy, PhD, FRCP(UK) Oluwaseun Falade-Nwulia, MBBS, MPH Joseph K. Lim, MD Released: October 11, 2021

Clinical Care Options (CCO) video featuring Drs. Greg Dore and Stacey Trooskin discussing lessons on HCV care learned during COVID-19 lockdown

Gregory Dore, MBBS, PhD, FRACP, MPH Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 1, 2021 Expired: September 30, 2022

Expert commentary on the utility of telemedicine visits in HCV care, from Dr. Stacey Trooskin and Clinical Care Options (CCO)

Stacey Trooskin, MD, PhD, MPH Released: September 29, 2021

Takeshi Saito, MD, PhD, discusses the limitations of current approaches to treating HDV and looks ahead to new and emerging HDV therapies, from Clinical Care Options (CCO)

Takeshi Saito, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 28, 2021 Expired: September 27, 2022